Crossmark

Clinical significance of T cell metabolic reprogramming in cancer

Crossref DOI link: https://doi.org/10.1186/s40169-016-0110-9

Published Online: 2016-08-10

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Herbel, Christoph

Patsoukis, Nikolaos

Bardhan, Kankana

Seth, Pankaj

Weaver, Jessica D.

Boussiotis, Vassiliki A. https://orcid.org/0000-0002-3963-1518
Funding

Funding for this research was provided by:

National Institutes of Health (CA183605, CA183605S1, AI098129‐01)

U.S. Department of Defense (PC140571)

National Cancer Institute (CA183605, CA183605S1)

Foundation for the National Institutes of Health (AI098129-01)

U.S. Department of Defense (PC140571, PC140571)
License Information

Version of Record valid from 2016-08-10

Text and Data Mining valid from 2016-08-10

Version of Record valid from 2016-08-10
More Information

Article History

Received: 12 April 2016

Accepted: 15 July 2016

First Online: 10 August 2016